Syngene International to Showcase Small Molecule & Biologics Capabilities at CPHI North America 2024
Syngene International (BSE: 539268, NSE: SYNGENE, ISIN: INE398R01022), a leading integrated contract research, development, and manufacturing organisation, announces its participation as an exhibitor at CPHI North America 2024, held at...